Xixian Wang

Ueruemqi, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Global, Regional, and National Burden of Brain and Central Nervous System Cancer, with a Secondary Analysis of Retinoblastoma, 1990-2021: Analysis for the Global Burden of Disease Study.

Global, Regional, and National Burden of Brain and Central Nervous System Cancer, with a Secondary Analysis of Retinoblastoma, 1990-2021: Analysis for the Global Burden of Disease Study.

Journal: World neurosurgery

Published: June 14, 2025

Unraveling the shared genetic foundations of neurodevelopmental and psychiatric disorders: Insights from comprehensive genome-wide analyses.

Unraveling the shared genetic foundations of neurodevelopmental and psychiatric disorders: Insights from comprehensive genome-wide analyses.

Journal: Journal of affective disorders

Published: September 15, 2024

Global, Regional, and National Burden of Brain and Central Nervous System Cancers for Males from 1990 to 2021 and Its Predicted Level in the Next 25 Years.

Global, Regional, and National Burden of Brain and Central Nervous System Cancers for Males from 1990 to 2021 and Its Predicted Level in the Next 25 Years.

Journal: Neuroepidemiology

Published: August 03, 2024

Correction: N7‑methylguanosin regulators‑mediated methylation modification patterns and characterization of the immune microenvironment in lower‑grade glioma.

Correction: N7‑methylguanosin regulators‑mediated methylation modification patterns and characterization of the immune microenvironment in lower‑grade glioma.

Journal: European journal of medical research

Published: January 19, 2024

Genomic Profiling of Lower-Grade Gliomas Subtype with Distinct Molecular and Clinicopathologic Characteristics via Altered DNA-Damage Repair Features.

Genomic Profiling of Lower-Grade Gliomas Subtype with Distinct Molecular and Clinicopathologic Characteristics via Altered DNA-Damage Repair Features.

Journal: Journal of molecular neuroscience : MN

Published: December 26, 2022

N7-methylguanosin regulators-mediated methylation modification patterns and characterization of the immune microenvironment in lower-grade glioma.

N7-methylguanosin regulators-mediated methylation modification patterns and characterization of the immune microenvironment in lower-grade glioma.

Journal: European journal of medical research

Published: November 03, 2022

An innovative prognostic model based on autophagy-related long noncoding RNA signature for low-grade glioma.

An innovative prognostic model based on autophagy-related long noncoding RNA signature for low-grade glioma.

Journal: Molecular and cellular biochemistry

Published: August 24, 2021

Identification and validation of a novel eight mutant-derived long non-coding RNAs signature as a prognostic biomarker for genome instability in low-grade glioma.

Identification and validation of a novel eight mutant-derived long non-coding RNAs signature as a prognostic biomarker for genome instability in low-grade glioma.

Journal: Aging

Published: February 18, 2021

Integrated Gene Expression and Methylation Analyses Identify DLL3 as a Biomarker for Prognosis of Malignant Glioma.

Integrated Gene Expression and Methylation Analyses Identify DLL3 as a Biomarker for Prognosis of Malignant Glioma.

Journal: Journal of molecular neuroscience : MN

Published: December 05, 2020

Identification and validation of an individualized prognostic signature of lower-grade glioma based on nine immune related long non-coding RNA.

Identification and validation of an individualized prognostic signature of lower-grade glioma based on nine immune related long non-coding RNA.

Journal: Clinical neurology and neurosurgery

Published: October 31, 2020

Showing 1-10 of 10

Last Updated: 09/26/2026